COVERAGE: Private Plans To Blame for Part D's High Costs

Why This Topic Matters

It helps readers understand a major Medicare policy debate about whether private insurers or a centrally administered benefit is likely to be more cost-efficient, and it frames the discussion in terms of projected government spending and administrative costs.

Article Sections

1. Multiple Cost Scenarios Reveal Multiple Cost-Cutting Opportunities

   This section summarizes alternative cost projections for a centrally administered Medicare drug benefit and discusses the types of savings evaluated in the study. It focuses on broad budget-period comparisons and administrative cost assumptions.

2. Competition Fails To Drive Down Costs

   This section reviews the study’s critique of the private-plan structure in Medicare Part D and the policy factors examined as drivers of higher costs. It also addresses the role of federal pricing authority and the expected impact of different plan designs.